Tag: opzelura

All

FDA Extends Review of Opzelura for Pediatric Atopic Dermatitis

Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.

All

Sorry, No Posts Found

All

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.

HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors
Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction
Survey Reveals Knowledge Gap on Menopause-Related Skin Changes

Tag: opzelura

All

FDA Extends Review of Opzelura for Pediatric Atopic Dermatitis

All

Sorry, No Posts Found

All

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors

Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction

Survey Reveals Knowledge Gap on Menopause-Related Skin Changes

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links